Keywords
Diabetes Mellitus, Type 1 ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

132 Search results.

Eligibility Insulin Dependent Diabetes NCT01745900

- 4/21/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations; ODM derived from: https://clinicaltrials.gov/show/NCT01745900

Eligibility Type 1 Diabetes NCT01354288

- 12/19/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Therapeutic Education in Very Young Children With Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01354288

Eligibility Diabetics Mellitus Type 1 NCT01594801

- 11/22/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Testing the Effect of the InsuPad Device in Daily Life Conditions; ODM derived from: https://clinicaltrials.gov/show/NCT01594801

Eligibility Diabetes NCT02098395

- 11/17/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02098395

Eligibility Diabetes NCT01836523

- 11/15/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01836523

Eligibility Diabetes NCT01513473

- 11/13/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01513473

Eligibility Diabetes NCT01074268

- 11/10/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01074268

Eligibility Diabetes NCT01079234

- 11/10/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01079234

Eligibility Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 NCT02103595

- 11/8/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.; ODM derived from: https://clinicaltrials.gov/show/NCT02103595

Eligibility Type 1 Diabetes Mellitus NCT02408705

- 7/26/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT02408705

Eligibility Type 1 Diabetes Mellitus NCT02421510

- 7/15/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT02421510

Eligibility Type 1 Diabetes Mellitus NCT02514954

- 7/15/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT02514954